STOCK TITAN

Concentra Group Holdings Parent (CON) Form 4 Filings

CON NYSE

Here are the Form 4 insider transactions from Concentra Group Holdings Parent, Inc. (CON) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CON and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CON filings page.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. director Brigid A. Bonner received a grant of 3,989 shares of restricted stock on November 3, 2026, bringing her direct common stock holdings to 19,485 shares.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. director Cheryl Pegus received a grant of 3,989 shares of restricted stock on November 3, 2026. Following the grant, she directly held 24,729 shares. The restricted stock, subject to certain exceptions, will vest in full on November 3, 2027, the first anniversary of the grant date.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. reported that Executive Vice President and Chief People Officer Danielle Kendall received a direct grant of 33,245 shares of restricted stock on November 3, 2026. Her reported direct holdings after the grant were 109,310 shares.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. (CON) executive vice president, chief operating officer - West Douglas R. McAndrew received a grant of 53,191 shares of restricted stock on November 3, 2026. The shares are scheduled to vest in equal annual installments over four years. His reported direct common-stock holdings following the grant were 167,288 shares.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. director Daniel Thomas received a grant of 3,989 shares of restricted stock on November 3, 2026. His directly held position after the grant was 77,989 shares. Subject to certain exceptions, the award will vest in full on November 3, 2027.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. (CON) Executive Vice President and Chief Clinical Services Officer Giovanni Gallara acquired 53,191 shares of restricted stock on November 3, 2026, at $0.00 per share. The grant will vest in equal annual installments over four years. Gallara directly held 166,628 shares after the transaction.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. reported that Executive Vice President, Chief Reimbursement & Government Relations Officer Greg M. Gilbert received a 46,543-share restricted-stock award on November 3, 2026. The grant was recorded as a direct acquisition, bringing his reported direct common-stock holdings to 160,640 shares. The transaction is an award acquisition rather than a market purchase or sale.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. (CON) reports that Executive Vice President, Chief Growth & Customer Officer Jonathan P. Conser received an award of 53,191 shares of restricted stock on November 3, 2026. Conser held 167,288 shares directly following the award.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. (CON) Executive Vice President, Chief Information & Technology Officer John A. deLorimier received a grant of 46,543 shares of restricted stock on November 3, 2026. The shares will vest in equal annual installments over four years. His reported direct holdings after the grant were 160,115 shares of Common Stock.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. director and President & Chief Executive Officer Matthew T. DiCanio acquired 164,894 shares of restricted stock as a grant on November 3, 2026. His reported directly held position following the grant was 507,186 shares. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. (CON) officer Michael A. Kosuth, identified as Executive Vice President, Chief Operating Officer - East, received a grant of 53,191 shares of restricted stock on November 3, 2026. His reported direct common-stock holdings after the grant were 166,742 shares.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. (CON) Executive Vice President and Chief Operating Officer, Onsite Health & Telemedicine, Michael D. Rhine acquired 43,883 shares of restricted stock on November 3, 2026, bringing his directly held shares to 120,046. The transaction is a restricted-stock grant, not a reported market purchase.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. (CON) director Marc R. Watkins acquired 3,989 shares of common stock as a grant of restricted stock on November 3, 2026. His directly held common stock position after the grant was 24,729 shares. The restricted stock will vest in full on November 3, 2027, subject to certain exceptions.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. director Robert A. Ortenzio acquired 3,989 shares of restricted stock on November 3, 2026. The award is scheduled to vest in full on November 3, 2027, subject to certain exceptions. His reported direct holdings after the award were 4,667,783 shares. Reported indirect holdings included 882,115 shares in the Robert A. Ortenzio Descendants Trust; 196,286 shares in each of the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio and the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio; 206,286 shares in the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio; and 503,455 shares in the Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. (CON) reports that Executive Vice President, Chief Marketing and Innovation Officer Thomas A. Devasia acquired 41,223 shares of restricted stock as a grant on November 3, 2026. His direct holdings following the grant were 155,320 shares.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. (CON) reports that Executive Vice President and Chief Legal Counsel Timothy F. Ryan acquired 46,543 shares of restricted stock on November 3, 2026. His reported direct holding after the transaction was 160,640 shares. The transaction was a grant/award acquisition, not a market purchase.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. director Vipin Gopal acquired a 3,989-share restricted stock award on November 3, 2026. The award is held directly and, subject to certain exceptions, will vest in full on November 3, 2027.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. director William Keith Newton acquired 138,812 shares of restricted stock on November 3, 2026. The award vests in equal annual installments over four years. His directly held common stock position following the award was 532,562 shares. A separate holding entry lists 89,081 shares held indirectly by the Cynthia Lee Newton Beneficiary Trust.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. (CON) EVP & Chief Financial Officer Raymond Tanner Newton received a grant of 55,851 shares of common stock on November 3, 2026. The award is restricted stock that will vest in equal annual installments over four years.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. (CON) reported that director Robert A. Ortenzio and related trusts disposed of common stock to the company on August 21, 2026, in transactions already previously reported. The amendment corrects administrative errors and adds an omitted indirect holding, without introducing new transactions. Under a Stock Repurchase Agreement, the company agreed to repurchase an aggregate of 1,000,000 shares at $34.65 per share, including 770,000 shares held directly by Ortenzio and 230,000 shares held through trusts for his descendants. After these dispositions, Ortenzio directly holds 4,663,794 shares, with additional indirect holdings through several family trusts, including 882,115 shares in the Descendants Trust and 196,286 or 206,286 shares in each of several 2014 trusts. A separate 503,455-share indirect holding in the Rocco A. Ortenzio Separate Descendants Trust was also reported as a holding entry, with no change in beneficial ownership. The Audit Committee of the board, consisting solely of Non-Employee Directors, approved the dispositions for exemption under Rule 16b-3(e).

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. (CON) entered into a Stock Repurchase Agreement under which it purchased an aggregate of 1,000,000 shares of common stock at $34.65 per share from director Robert A. Ortenzio and related trusts. Ortenzio disposed of 770,000 shares held directly and 230,000 shares held indirectly through family trusts. After these dispositions, he holds 4,763,794 shares directly, with additional shares held indirectly through the named trusts. The Audit Committee of Concentra’s board, composed solely of Non-Employee Directors, approved the transactions for exemption from Section 16(b) under Rule 16b-3(e).

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. director Robert A. Ortenzio reported an open-market sale of 130,000 shares of common stock on 2026-08-03 at a weighted average price of $31.8412 per share, with individual trade prices between $31.65 and $32.035. The shares were sold indirectly by The Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio, which held 503,455 shares after the transaction. He also reported 5,533,794 shares held directly and additional indirect holdings through several family trusts, and indicated the transaction was carried out under a trading plan.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. director Robert A. Ortenzio reported an indirect open-market sale of 130,000 shares of common stock on July 1, 2026 at a weighted average price of $30.4969 per share. The sale was executed by The Rocco A. Ortenzio Separate Descendants Trust for the benefit of Robert Ortenzio, which held 633,455 shares after the transaction. Additional indirect holdings are shown in several family trusts, and a separate line reflects 5,533,794 shares held directly as of the same date.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. director Robert A. Ortenzio reported an indirect open-market sale of 130,000 shares of Common Stock on June 1, 2026 by The Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio.

The shares were sold at a weighted average price of $25.0002 per share, with individual sale prices ranging from $25.00 to $25.03. Following this transaction, the trust still holds 763,455 shares of Common Stock.

Additional entries show indirect holdings of 226,286 shares in each of several 2014 trusts and 1,032,115 shares in the Robert A. Ortenzio Descendants Trust, as well as a separate direct holding of 5,533,794 shares of Common Stock.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. director Robert A. Ortenzio reported an indirect open-market sale of 130,000 shares of common stock at $25.00 per share. The sale was made by The Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio, which held 893,455 shares afterward. Additional indirect family trusts and direct holdings include 5,533,794 shares reported as directly owned.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. reported an insider transaction by its Chief Executive Officer and director involving a gift of common stock. On December 17, 2025, the reporting person made a gift of 89,081 shares of common stock to the Cynthia Lee Newton Beneficiary Trust, recorded at a price of $0 per share under transaction code G.

Following the transaction, the reporting person holds 393,750 shares of common stock directly. The Form 4 also shows 89,081 shares held indirectly through the Cynthia Lee Newton Beneficiary Trust. The filing explains that the reporting person is not a trustee of the trust, does not control its investments, and therefore has no reportable pecuniary interest in the shares held by the trust.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. executive Timothy F. Ryan reported a routine share withholding related to equity compensation. On 11/26/2025, 5,903 shares of common stock were disposed of at $21.04 per share under transaction code “F,” indicating shares were withheld to cover tax obligations from the vesting of restricted stock. After this transaction, he beneficially owned 114,097 shares of common stock directly. Ryan serves as Executive Vice President & Chief Legal Counsel, and this filing reflects administrative management of taxes on equity awards rather than an open-market sale.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. reported an insider share disposition by one of its executives. On 11/26/2025, an officer disposed of 3,935 shares of common stock at $21.04 per share, leaving 76,163 shares beneficially owned after the transaction. The filing classifies the transaction under code F, and the explanation states that the shares were withheld to satisfy tax obligations arising from the vesting of restricted stock. The reporting person serves as Executive Vice President and Chief Operating Officer, Onsite Health & Telemedicine, and the ownership is reported as held directly.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. reported an insider share transaction by an executive officer. On 11/26/2025, the Executive Vice President and Chief Accounting Officer had 5,903 shares of common stock withheld at a price of $21.04 per share to cover tax obligations from the vesting of restricted stock. After this tax withholding, the officer beneficially owned 114,097 shares of common stock directly.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. reported an insider equity transaction by an executive officer. On 11/26/2025, common stock totaling 5,903 shares was disposed of at a price of $21.04 per share. The filing explains that these shares were withheld to cover tax obligations from the vesting of restricted stock, rather than an open-market sale. After this tax withholding, the reporting person beneficially owned 114,097 shares of common stock directly.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. reported an insider transaction by its Executive Vice President and Chief Operating Officer - East. On 11/26/2025, 6,449 shares of common stock were disposed of at a price of $21.04 per share, coded as an "F" transaction, which means the shares were withheld to cover tax obligations arising from the vesting of restricted stock rather than an open market sale. Following this tax-withholding event, the executive directly beneficially owned 113,551 shares of Concentra common stock.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. insider reports tax-related share withholding. An executive officer reported a Form 4 transaction involving the company’s common stock on 11/26/2025. A total of 5,903 shares of common stock were disposed of in a transaction coded “F,” meaning the shares were withheld by the company to satisfy tax obligations triggered by the vesting of restricted stock, rather than sold on the open market.

After this tax-withholding event, the reporting person beneficially owns 114,097 shares of Concentra Group Holdings Parent, Inc. common stock in direct ownership form. The filer serves as Executive Vice President, Chief Reimbursement & Government Relations Officer, and filed as a single reporting person.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. insider trading report: A company officer reported a routine share withholding related to equity compensation. On 11/26/2025, 17,708 shares of common stock were disposed of at $21.04 per share under transaction code "F," which indicates shares were withheld to cover tax obligations from the vesting of restricted stock. After this transaction, the reporting person directly beneficially owned 342,292 shares of common stock. The reporting person serves as President & Chief Financial Officer of Concentra Group Holdings Parent, Inc.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. reported an insider transaction by its Executive Vice President, Chief Marketing and Innovation Officer. On 11/26/2025, the officer had 5,903 shares of common stock disposed of at $21.04 per share, coded as an "F" transaction, meaning the shares were withheld to cover tax obligations from the vesting of restricted stock. After this tax withholding, the officer directly beneficially owned 114,097 shares of Concentra common stock.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. reported an insider equity transaction by its Executive Vice President, Chief Digital & Data Officer. On 11/26/2025, the officer had 6,428 shares of common stock withheld at a price of $21.04 per share to cover tax obligations related to the vesting of restricted stock. After this tax withholding, the officer directly beneficially owns 113,572 shares of common stock. This type of transaction is administrative and does not represent an open-market purchase or sale.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. reported an insider transaction by an executive officer. On 11/26/2025, the Executive Vice President, Chief Growth & Customer Officer had 5,903 shares of common stock withheld and disposed of at $21.04 per share to cover tax obligations from the vesting of restricted stock. After this tax withholding, the officer directly beneficially owned 114,097 shares of Concentra common stock.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. executive shares were adjusted in connection with equity compensation. On 11/26/2025, an officer identified as the Executive Vice President and Chief Medical Officer reported a Form 4 transaction in the company’s common stock. A total of 6,540 shares of common stock were disposed of at $21.04 per share under transaction code F, which indicates shares were withheld to cover tax obligations arising from the vesting of restricted stock.

After this tax withholding event, the reporting person directly beneficially owned 113,460 shares of Concentra Group Holdings Parent, Inc. common stock. The filing reflects an administrative adjustment related to equity compensation rather than an open‑market purchase or sale.

Rhea-AI Summary

Concentra Group Holdings Parent, Inc. (CON) director reported an insider stock transfer. On 11/25/2025, the reporting person made a bona fide gift of 100,000 shares of common stock, shown with transaction code G and a price of $0 per share, which reflects the nature of a gift rather than a sale.

After this transaction, the director directly held 5,433,794 shares of common stock. The report also lists additional indirect beneficial ownership through several family trusts, including 1,023,455 shares held by The Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio and 1,032,115 shares held by the Robert A. Ortenzio Descendants Trust, plus three 2014 trusts each holding 226,286 shares for individual beneficiaries.